Ridha Joober developed a pharmaco-genetic profile of schizophrenia that may lead to earlier diagnosis and more effective treatment.

Jacques Tremblay is actively involved in quality assurance, and in improving the safety of medication use.

Mimi Israël is active in eating disorders, affective disorders, crisis intervention, emergency psychiatry and mental health care service organization.

Alain Brunet, PhD, studies risk factors and develops effective treatments for PTSD, such as early intervention and reconsolidation blockade.

Jean-Bruno Debruille studies the processes that precede and permit the conscious perception using fMRI and ERPs.

Thomas Brown studies the development of psychosocial interventions to combat substance abuse.

Véronique Bohbot investigates the neural correlates underlying visual and auditory spatial memory in normal and brain-damaged individuals.

Serge Beaulieu studies neurobiological responses to antidepressant and mood stabilizer treatment in bipolar disorders.

Jorge Armony, PhD conducts research on how the brain detects danger stimuli and how it interacts with consciousness and memory.